Other sickle-cell disorders with splenic sequestration
ICD-10 D57.812 is a billable code used to indicate a diagnosis of other sickle-cell disorders with splenic sequestration.
D57.812 refers to a specific type of sickle-cell disorder characterized by splenic sequestration, a serious complication where sickle-shaped red blood cells become trapped in the spleen, leading to acute splenic enlargement and a sudden drop in hemoglobin levels. This condition is particularly prevalent in children with sickle cell disease and can result in severe anemia, pain, and potential life-threatening complications. The pathophysiology involves the abnormal shape of red blood cells, which can obstruct blood flow in the spleen, causing congestion and splenic infarction. Patients may present with symptoms such as abdominal pain, pallor, fatigue, and signs of shock in severe cases. Management typically includes hydration, pain control, and sometimes blood transfusions to alleviate anemia. Understanding the genetic basis of sickle cell disease, which is caused by a mutation in the HBB gene on chromosome 11, is crucial for diagnosis and treatment. This code is essential for capturing the complexity of sickle-cell disorders and their complications in clinical documentation and billing.
Detailed clinical notes on hemoglobin levels, splenic size, and management strategies.
Patients presenting with acute splenic sequestration crisis, chronic pain management, and transfusion therapy.
Ensure accurate coding of complications and comorbidities related to sickle cell disease.
Growth charts, developmental assessments, and family history of sickle cell disease.
Children with recurrent pain crises, splenic sequestration episodes, and routine health maintenance.
Focus on age-specific manifestations and management strategies for pediatric patients.
Used during acute management of splenic sequestration.
Document the indication for transfusion and patient response.
Hematology specialists should ensure compliance with transfusion protocols.
Coding D57.812 accurately captures the complexity of sickle cell disorders with splenic sequestration, ensuring appropriate management and reimbursement for the care provided.
